Characterization of the novel HLA‐B*40:539 allele by sequencing‐based typing
HLA · 2024
DOI: 10.1111/tan.15246 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Vincent Elsermans und 4 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Lille, Institut d'Immunologie-HLA, Lille, France. Hauptthemen laut MEDLINE: Genes, MHC Class I, HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*40:539 differs from HLA‐B*40:01:01 by one nucleotide substitution in codon 46 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU de Lille, Institut d'Immunologie-HLA, Lille, France.
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
- Université de Bordeaux, UMR CNRS 5164 Immunoconcept, Bordeaux, France.
- Université de Lille, Inserm U1286 INFINITE, Lille, France.
ORCID-Profile: Jonathan Visentin
Zitieren
APA
Elsermans, V., Visentin, J., Top, I., Pajot, T., & Labalette, M. (2024). Characterization of the novel HLA‐B*40:539 allele by sequencing‐based typing. HLA. https://doi.org/10.1111/tan.15246
Vancouver
Elsermans V, Visentin J, Top I, Pajot T, Labalette M. Characterization of the novel HLA‐B*40:539 allele by sequencing‐based typing. HLA. 2024. doi:10.1111/tan.15246
BibTeX
@article{Elsermans2024,
author = {Elsermans, Vincent and Visentin, Jonathan and Top, Isabelle and Pajot, Thibault and Labalette, Myriam},
title = {Characterization of the novel HLA‐B*40:539 allele by sequencing‐based typing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15246}
}
EUVIMED